Bevacizumab Biosimilar - Research Grade
Product Sizes
1 mg
ICH4003-1MG
5 mg
ICH4003-5MG
10 mg
ICH4003-10MG
20 mg
ICH4003-20MG
50 mg
ICH4003-50MG
100 mg
ICH4003-100MG
200 mg
ICH4003-200MG
500 mg
ICH4003-500MG
1 g
ICH4003-1G
About this Product
- SKU:
- ICH4003
- Additional Names:
- Vascular endothelial growth factor
- CE/IVD:
- RUO
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 1-5 mg/ml
- Extra Details:
- Bevacizumab biosimilar is vascular endothelial growth factor directed antibody. Bevacizumab biosimilar is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab biosimilar has an approximate molecular weight of 149 kDa. Bevacizumab is produced in a mammalian cell (Chinese Hamster Ovary) expression system in a nutrient medium.
- Formulation:
- Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
- Host:
- Human
- Immunogen:
- VEGF
- Isotype:
- IgG1
- Purity:
- >95%
- Purification:
- Protein A/G Purified
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Specificity:
- Detects human VEGF. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Bevacizumab.
- Storage Conditions:
- 2-8[o]C Aliquot. Avoid freeze/thaw cycles.
- Supplier:
- ichorbio
- Type:
- Antibody: Biosimilar Antibody
- Shipping Costs:
- Free shipping to UK Customers
- Manufacturer's Data Sheet:https://ichor.bio/productpdf/print/index/url_key/bevacizumab-biosimilar-research-grade/

